Winning With Real World
Evidence & AI
Unlock Market Access &
Utilize Real-World evidence to support
We work with Amazing Brands
Our clients include over 20% of the 50 largest life science companies in the world by market capitalization, we're also behind the success of many smaller category leaders across a broad range of therapeutic areas.
Explore how your business can get smarter
Global Pricing | Reimbursement
Map Global Reimbursement & Coverage Landscape, Perform Primary Research with Payers to Inform Trial Design & Go No Go Decisions.
Economic Models | Evidence Synthesis
Planning for evidence generation and synthesis to support economic models must therefore start early in product development.
Comparative Effectiveness | Real World Evidence
Quantitative research into treatment, disease burden, and resource use to inform multiple elements of the market access strategy.
Global Payer | KOL Advisory Boards
Identify & Engage all relevant KOLs and Payers around the globe based on tailored segmentation criteria with a Digital Interface.
Disrupt or be disrupted, Explore Game Changing Innovation Based on Predictive Analytics and Design Thinking. Scout Innovation more effectively, expand your global reach.
Explore strategies to optimize patient-reported outcomes to support the value proposition to regulators, reimbursement agencies, and patients.
AI Driven Outcomes with P&T Committees'
Transform Market Access & Reach Payer Decision Makers.
Payer Readiness Assessment (PRA)
PRA™ is a strategic planning tool designed to evaluate the planned and required evidence for your product on a country-by-country basis.
HCP MultiChannel Content
Maximize Adoption with Content Ai Linked to Real World Evidence.